Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $5,143 | 1 | 76.6% |
| Unspecified | $1,569 | 8 | 23.4% |
Payments by Type
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $5,143 | 1 | $0 (2022) |
| Regeneron Pharmaceuticals, Inc. | $1,569 | 8 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2023 | $581.16 | 5 | Regeneron Pharmaceuticals, Inc. ($581.16) |
| 2022 | $5,818 | 2 | AstraZeneca Pharmaceuticals LP ($5,143) |
| 2021 | $311.78 | 2 | Regeneron Pharmaceuticals, Inc. ($311.78) |
All Payment Transactions
9 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/07/2023 | Regeneron Pharmaceuticals, Inc. | LIBTAYO (Biological) | — | In-kind items and services | $234.37 | Research |
| Study: LIBTAYO CLINICAL PUBLICATION PROGRAM • Category: ONCOLOGY | ||||||
| 12/07/2023 | Regeneron Pharmaceuticals, Inc. | LIBTAYO (Biological) | — | In-kind items and services | $49.25 | Research |
| Study: LIBTAYO CLINICAL PUBLICATION PROGRAM • Category: ONCOLOGY | ||||||
| 12/07/2023 | Regeneron Pharmaceuticals, Inc. | LIBTAYO (Biological) | — | In-kind items and services | $32.57 | Research |
| Study: LIBTAYO CLINICAL PUBLICATION PROGRAM • Category: ONCOLOGY | ||||||
| 04/14/2023 | Regeneron Pharmaceuticals, Inc. | LIBTAYO (Biological) | — | In-kind items and services | $225.53 | Research |
| Study: LIBTAYO CLINICAL PUBLICATION PROGRAM • Category: ONCOLOGY | ||||||
| 02/02/2023 | Regeneron Pharmaceuticals, Inc. | LIBTAYO (Biological) | — | In-kind items and services | $39.44 | Research |
| Study: LIBTAYO CLINICAL PUBLICATION PROGRAM • Category: ONCOLOGY | ||||||
| 06/02/2022 | AstraZeneca Pharmaceuticals LP | IMFINZI (Biological) | Consulting Fee | Cash or cash equivalent | $5,142.50 | General |
| Category: Oncology | ||||||
| 01/17/2022 | Regeneron Pharmaceuticals, Inc. | LIBTAYO (Biological) | — | In-kind items and services | $675.68 | Research |
| Study: LIBTAYO CLINICAL PUBLICATION PROGRAM • Category: ONCOLOGY | ||||||
| 04/10/2021 | Regeneron Pharmaceuticals, Inc. | LIBTAYO (Biological) | — | In-kind items and services | $213.67 | Research |
| Study: LIBTAYO CLINICAL PUBLICATION PROGRAM • Category: ONCOLOGY | ||||||
| 02/11/2021 | Regeneron Pharmaceuticals, Inc. | LIBTAYO (Biological) | — | In-kind items and services | $98.11 | Research |
| Study: LIBTAYO CLINICAL PUBLICATION PROGRAM • Category: ONCOLOGY | ||||||
Research Studies & Clinical Trials
| Study Name | Company | Amount | Records |
|---|---|---|---|
| LIBTAYO CLINICAL PUBLICATION PROGRAM | Regeneron Pharmaceuticals, Inc. | $1,569 | 8 |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 12 | 1,651 | 3,751 | $833,990 | $184,286 |
| 2022 | 13 | 1,882 | 4,135 | $779,764 | $206,908 |
| 2021 | 12 | 1,504 | 3,420 | $727,307 | $194,150 |
| 2020 | 7 | 968 | 2,109 | $468,720 | $123,954 |
All Medicare Procedures & Services
61 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 88305 | Pathology examination of tissue using a microscope, intermediate complexity | Office | 2023 | 467 | 1,371 | $328,822 | $85,305 | 25.9% |
| 88342 | Special stained specimen slides to examine tissue, initial procedure | Office | 2023 | 177 | 295 | $110,667 | $26,552 | 24.0% |
| 88305 | Pathology examination of tissue using a microscope, intermediate complexity | Facility | 2023 | 254 | 552 | $78,198 | $16,895 | 21.6% |
| 88350 | Antibody evaluation, each additional single antibody stain procedure | Facility | 2023 | 48 | 382 | $62,204 | $9,428 | 15.2% |
| 88313 | Special stained specimen slides to examine tissue including interpretation and report | Office | 2023 | 88 | 121 | $31,339 | $9,025 | 28.8% |
| 88342 | Special stained specimen slides to examine tissue, initial procedure | Facility | 2023 | 172 | 259 | $39,953 | $7,618 | 19.1% |
| 88341 | Special stained specimen slides to examine tissue, each additional procedure | Office | 2023 | 30 | 96 | $30,708 | $7,436 | 24.2% |
| 88341 | Special stained specimen slides to examine tissue, each additional procedure | Facility | 2023 | 84 | 210 | $28,086 | $5,046 | 18.0% |
| 88307 | Pathology examination of tissue using a microscope, moderately high complexity | Facility | 2023 | 58 | 68 | $29,565 | $4,666 | 15.8% |
| 88348 | Electron microscopy for diagnosis | Facility | 2023 | 49 | 53 | $33,190 | $3,463 | 10.4% |
| 88309 | Pathology examination of tissue using a microscope, high complexity | Facility | 2023 | 18 | 20 | $16,663 | $2,350 | 14.1% |
| 88313 | Special stained specimen slides to examine tissue including interpretation and report | Facility | 2023 | 99 | 200 | $18,824 | $1,943 | 10.3% |
| 88312 | Special stained specimen slides to identify organisms including interpretation and report | Office | 2023 | 15 | 16 | $5,680 | $1,664 | 29.3% |
| 88346 | Antibody evaluation, initial single antibody stain procedure | Facility | 2023 | 48 | 51 | $11,612 | $1,524 | 13.1% |
| 88360 | Microscopic genetic analysis of tumor, manual | Facility | 2023 | 21 | 32 | $6,879 | $1,135 | 16.5% |
| 88304 | Pathology examination of tissue using a microscope, moderately low complexity | Facility | 2023 | 23 | 25 | $1,600 | $236.16 | 14.8% |
| 88305 | Pathology examination of tissue using a microscope, intermediate complexity | Office | 2022 | 510 | 1,319 | $316,800 | $85,591 | 27.0% |
| 88342 | Special stained specimen slides to examine tissue, initial procedure | Office | 2022 | 187 | 291 | $109,416 | $28,077 | 25.7% |
| 88350 | Antibody evaluation, each additional single antibody stain procedure | Facility | 2022 | 88 | 773 | $75,754 | $20,054 | 26.5% |
| 88305 | Pathology examination of tissue using a microscope, intermediate complexity | Facility | 2022 | 267 | 513 | $67,203 | $16,837 | 25.1% |
| 88313 | Special stained specimen slides to examine tissue including interpretation and report | Office | 2022 | 97 | 161 | $41,699 | $12,719 | 30.5% |
| 88348 | Electron microscopy for diagnosis | Facility | 2022 | 99 | 113 | $29,606 | $7,889 | 26.6% |
| 88342 | Special stained specimen slides to examine tissue, initial procedure | Facility | 2022 | 189 | 257 | $31,611 | $7,884 | 24.9% |
| 88341 | Special stained specimen slides to examine tissue, each additional procedure | Facility | 2022 | 91 | 191 | $18,909 | $4,792 | 25.3% |
| 88307 | Pathology examination of tissue using a microscope, moderately high complexity | Facility | 2022 | 48 | 60 | $17,220 | $4,378 | 25.4% |
About Stephen Ward, M.D., PH.D
Stephen Ward, M.D., PH.D is a Anatomic Pathology healthcare provider based in New York, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/02/2008. The National Provider Identifier (NPI) number assigned to this provider is 1063688778.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Stephen Ward, M.D., PH.D has received a total of $6,711 in payments from pharmaceutical and medical device companies, with $581.16 received in 2023. These payments were reported across 9 transactions from 2 companies. The most common payment nature is "Consulting Fee" ($5,143).
As a Medicare-enrolled provider, Ward has provided services to 6,005 Medicare beneficiaries, totaling 13,415 services with total Medicare billing of $709,297. Data is available for 4 years (2020–2023), covering 61 distinct procedure/service records.
Practice Information
- Specialty Anatomic Pathology
- Location New York, NY
- Active Since 05/02/2008
- Last Updated 05/02/2008
- Taxonomy Code 207ZP0101X
- Entity Type Individual
- NPI Number 1063688778
Products in Payments
- IMFINZI (Biological) $5,143
- LIBTAYO (Biological) $1,569
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Anatomic Pathology Doctors in New York
Dr. Richard Axel, M.d, M.D
Anatomic Pathology — Payments: $96,602
Dr. Jeremy Segal, M.d., Ph.d, M.D., PH.D
Anatomic Pathology — Payments: $92,539
Marc Ladanyi, Md, MD
Anatomic Pathology — Payments: $74,599
Dr. Maureen Zakowski, Md, MD
Anatomic Pathology — Payments: $45,149
Victor Reuter, Md, MD
Anatomic Pathology — Payments: $44,326
Dr. Alexandros Polydorides, M.d., Ph.d, M.D., PH.D
Anatomic Pathology — Payments: $34,029